Clinical Trial Update: Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria [Phase 3]

View source ↗

Summary

This Phase 3 trial compared chlorproguanil-dapsone-artesunate with Coartem (artemether-lumefantrine) for uncomplicated Plasmodium falciparum malaria and is repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum

Drugs mentioned

• Chlorproguanil-Dapsone-Artesunate (Chlorproguanil-Dapsone-Artesunate)
• Coartem (artemether-lumefantrine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Falciparum | Phase 3 | Status: COMPLETED